IDEXX Laboratories Inc
IDXX699.878USD
-4.322-0.61%
Market hours （ET）Quotes delayed by 15 min
55.99BMarket Cap
55.08P/E TTM
More Details of IDEXX Laboratories Inc Company
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
IDEXX Laboratories Inc Info
Ticker SymbolIDXX
Company nameIDEXX Laboratories Inc
IPO dateJun 21, 1991
CEOEmerson (Andrew)
Number of employees11000
Security typeOrdinary Share
Fiscal year-endJun 21
AddressOne Idexx Drive
CityWESTBROOK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code04092-2041
Phone12075560300
Websitehttps://www.idexx.com/
Ticker SymbolIDXX
IPO dateJun 21, 1991
CEOEmerson (Andrew)
Company Executives of IDEXX Laboratories Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
Other
-697.43M
-62.86%
By RegionUSD
Name
Revenue
Proportion
United States
717.87M
64.70%
Europe & Middle East & Africa (EMEA) (Region)
233.27M
21.03%
Asia Pacific
89.30M
8.05%
Canada
46.69M
4.21%
Latin America
22.33M
2.01%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
Other
-697.43M
-62.86%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.43%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
Other
70.21%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.43%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
Other
70.21%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.77%
Investment Advisor/Hedge Fund
30.95%
Research Firm
3.98%
Pension Fund
2.91%
Bank and Trust
1.86%
Individual Investor
0.69%
Sovereign Wealth Fund
0.59%
Hedge Fund
0.54%
Family Office
0.50%
Other
4.22%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2319
77.76M
97.19%
-4.03M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
9.84M
12.3%
+19.20K
+0.20%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.30M
6.63%
-132.86K
-2.44%
Jun 30, 2025
State Street Investment Management (US)
3.55M
4.44%
-95.45K
-2.62%
Jun 30, 2025
Fundsmith LLP
2.64M
3.3%
-9.04K
-0.34%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.46M
3.08%
+54.40K
+2.26%
Jun 30, 2025
Baron Capital Management, Inc.
2.03M
2.54%
-27.16K
-1.32%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
1.65M
2.06%
-5.80K
-0.35%
Aug 31, 2025
Principal Global Investors (Equity)
1.13M
1.41%
+1.75K
+0.16%
Jun 30, 2025
Polen Capital Management, LLC
1.20M
1.49%
+1.12M
+1519.07%
Jun 30, 2025
Walter Scott & Partners Ltd.
756.69K
0.95%
+597.11K
+374.18%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
ProShares Pet Care ETF
9.4%
iShares U.S. Medical Devices ETF
4.42%
First Trust Water ETF
3.98%
SMI 3Fourteen Full-Cycle Trend ETF
3.9%
Nuveen ESG Mid-Cap Growth ETF
3.47%
Adaptive Core ETF
2.61%
First Trust S&P 500 Economic Moat Index ETF
2.25%
Acruence Active Hedge US Equity ETF
2.18%
Tema Durable Quality ETF
2.1%
Putnam Sustainable Future ETF
2.03%
View more
ProShares Pet Care ETF
Proportion9.4%
iShares U.S. Medical Devices ETF
Proportion4.42%
First Trust Water ETF
Proportion3.98%
SMI 3Fourteen Full-Cycle Trend ETF
Proportion3.9%
Nuveen ESG Mid-Cap Growth ETF
Proportion3.47%
Adaptive Core ETF
Proportion2.61%
First Trust S&P 500 Economic Moat Index ETF
Proportion2.25%
Acruence Active Hedge US Equity ETF
Proportion2.18%
Tema Durable Quality ETF
Proportion2.1%
Putnam Sustainable Future ETF
Proportion2.03%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of IDEXX Laboratories Inc?
The top five shareholders of IDEXX Laboratories Inc are:
The Vanguard Group, Inc. holds 9.84M shares, accounting for 12.30% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 5.30M shares, accounting for 6.63% of the total shares.
State Street Investment Management (US) holds 3.55M shares, accounting for 4.44% of the total shares.
Fundsmith LLP holds 2.64M shares, accounting for 3.30% of the total shares.
Geode Capital Management, L.L.C. holds 2.46M shares, accounting for 3.08% of the total shares.
The Vanguard Group, Inc. holds 9.84M shares, accounting for 12.30% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 5.30M shares, accounting for 6.63% of the total shares.
State Street Investment Management (US) holds 3.55M shares, accounting for 4.44% of the total shares.
Fundsmith LLP holds 2.64M shares, accounting for 3.30% of the total shares.
Geode Capital Management, L.L.C. holds 2.46M shares, accounting for 3.08% of the total shares.
What are the top three shareholder types of IDEXX Laboratories Inc?
The top three shareholder types of IDEXX Laboratories Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
How many institutions hold shares of IDEXX Laboratories Inc (IDXX)?
As of 2025Q3, 2319 institutions hold shares of IDEXX Laboratories Inc, with a combined market value of approximately 77.76M, accounting for 97.19% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.54%.
What is the biggest source of revenue for IDEXX Laboratories Inc?
In FY2025Q2, the CAG Diagnostics recurring revenue business generated the highest revenue for IDEXX Laboratories Inc, amounting to 878.00M and accounting for 79.14% of total revenue.
